Publication | Closed Access

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia

Transplant RejectionGraft-versus-host DiseaseTransplantationMarrow TransplantationOncologySerotherapy RegimenStem Cell TransplantationImmunologyHematologyMarrow CellGraft SurvivalImmunotherapyMedicineCell TransplantationGraft Rejection